OTEZLA (apremilast)
PSORIATIC ARTHRITIS·+2
CELGENE
Indication
Oral ulcers associated with Behcet's disease
Oral ulcers associated with Behçet's disease are painful, recurrent mucosal lesions that represent the hallmark and often earliest clinical manifestation of this rare, chronic, multisystem vasculitis. Read more about Oral ulcers associated with Behcet's disease
6 drugs 3 manufacturers
Drugs that treat it
Common Oral ulcers associated with Behcet's disease therapies.
OTEZLA STARTER (apremilast)
PSORIATIC ARTHRITIS·+2
CELGENE/AMGEN
OTEZLA (apremilast)
ANTIPSORIATICS·PSORIATIC ARTHRITIS·+2
AMGEN
OTEZLA (apremilast)
PSORIATIC ARTHRITIS·+2
CELGENE/AMGEN
OTEZLA STARTER (apremilast)
ANTIPSORIATICS·PSORIATIC ARTHRITIS·+2
AMGEN
OTEZLA XR (apremilast)
ANTIPSORIATICS·PSORIATIC ARTHRITIS·+2
AMGEN
Filter & compare in the drug finder →Opens the drug finder with Oral ulcers associated with Behcet's disease preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOral ulcers associated with Behçet's disease are painful, recurrent mucosal lesions that represent the hallmark and often earliest clinical manifestation of this rare, chronic, multisystem vasculitis.
Primarily affecting young adults, this condition involves immune-mediated vascular and mucosal inflammation that typically targets the oral cavity—including the lips, tongue, buccal mucosa, and palate—alongside other systemic sites.
Clinically resembling recurrent aphthous stomatitis, the lesions manifest as discrete, circular or oval erythematous erosions with necrotic, yellowish-fibrinous bases.
Pathophysiologically, these ulcers arise from immune dysregulation characterized by aberrant neutrophil hyperactivity, endothelial injury, and elevated proinflammatory cytokine signaling that leads to tissue ulceration and substantial oral pain.
- nih.gov
Oral ulcers associated with Behçet's disease are painful, recurrent mucosal lesions that represent the hallmark and often earliest clinical manifestation of this rare, chronic, multisystem vasculitis Clinically resembling recurrent aphthous stomatitis, the lesions manifest as discrete, circular or oval erythematous erosions with necrotic, yellowish-fibrinous bases Pathophysiologically, these ulcers arise from immune dysregulation characterized by aberrant neutrophil hyperactivity, endothelial in...
- nih.gov
Oral ulcers associated with Behçet's disease are painful, recurrent mucosal lesions that represent the hallmark and often earliest clinical manifestation of this rare, chronic, multisystem vasculitis
- nih.gov
Oral ulcers associated with Behçet's disease are painful, recurrent mucosal lesions that represent the hallmark and often earliest clinical manifestation of this rare, chronic, multisystem vasculitis Primarily affecting young adults, this condition involves immune-mediated vascular and mucosal inflammation that typically targets the oral cavity—including the lips, tongue, buccal mucosa, and palate—alongside other systemic sites
- globalgenes.org
Primarily affecting young adults, this condition involves immune-mediated vascular and mucosal inflammation that typically targets the oral cavity—including the lips, tongue, buccal mucosa, and palate—alongside other systemic sites
- clevelandclinic.org
Primarily affecting young adults, this condition involves immune-mediated vascular and mucosal inflammation that typically targets the oral cavity—including the lips, tongue, buccal mucosa, and palate—alongside other systemic sites
- behcetsuk.org
Clinically resembling recurrent aphthous stomatitis, the lesions manifest as discrete, circular or oval erythematous erosions with necrotic, yellowish-fibrinous bases
- nih.gov
Pathophysiologically, these ulcers arise from immune dysregulation characterized by aberrant neutrophil hyperactivity, endothelial injury, and elevated proinflammatory cytokine signaling that leads to tissue ulceration and substantial oral pain
Personalize your experience
Follow Oral ulcers associated with Behcet's disease and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.